Chiara Tupini

Dr. Chiara Tupini

Life Sciences and Biotechnologies, University of Ferrara, Ferrara, Emilia-Romagna, Italy
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Journal of Organometallic Chemistry
Verified
Journal Article
Closed access
TSThomas Scattolin
Thomas Scattolin
NPNicola Pangerc
Nicola Pangerc
ILIlaria Lampronti
Ilaria Lampronti
Chiara TupiniChiara Tupini
Chiara Tupini
RGRoberto Gambari
Roberto Gambari
FVFabiano Visentin
Fabiano Visentin

8 February 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
ABAnna Baldisserotto
Anna Baldisserotto
RBRiccardo Barbari
Riccardo Barbari
Chiara TupiniChiara Tupini
Chiara Tupini
RBRaissa Buzzi
Raissa Buzzi
Elisa DuriniElisa Durini
Elisa Durini
Silvia VertuaniSilvia Vertuani
Silvia Vertuani
This research investigated plant extracts as a source of potential new actives in the nutritional, cosmetic, and pharmaceutical fields. Moringa oleifera, which is extensively known for its nutritional properties, has been investigated in this work by preparation, characterization, and evaluation of the antioxidant (FRAP, DPPH, ORAC, and PCL test), antifungal, photoprotective, and cytotoxicity profile against human melanoma Colo38 cell line of two different extracts (hydroalcoholic and methanolic) and one infusion of dry leaves collected from Paraguay in four distinct harvest times (February, March, April, and May 2017). The outcomes of this study highlight Moringa oleifera as a potential ally to counteract skin aging and oxidative stress, as indicated by the favorable antioxidant profile of the extracts and infusions of Paraguay, which was, in all cases, superior to that provided by the same plant species when collected from Senegal. Moreover, some samples were more efficient in preventing the photodegradation of UVA filter butyl methoxydibenzoylmethane (Avobenzone) compared to commercial filters, thus suggesting an interesting future role as natural additives in sunscreens.

Verified
Journal Article
Open access
PDF file
Federico ZappaterraFederico Zappaterra
Federico Zappaterra
Chiara TupiniChiara Tupini
Chiara Tupini
DSDaniela Summa
Daniela Summa
VCVirginia Cristofori
Virginia Cristofori
Stefania CostaStefania Costa
Stefania Costa
Elena TamburiniElena Tamburini
Elena Tamburini
Biocatalyzed synthesis can be exploited to produce high-value products, such as prodrugs. The replacement of chemical approaches with biocatalytic processes is advantageous in terms of environmental prevention, embracing the principles of green chemistry. In this work, we propose the covalent attachment of xylitol to ibuprofen to produce an IBU-xylitol ester prodrug. Xylitol was chosen as a hydrophilizer for the final prodrug, enhancing the water solubility of ibuprofen. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) extensively used as an analgesic, anti-inflammatory, and antipyretic. Despite being the third-most-prescribed medicine in the world, the aqueous solubility of ibuprofen is just 21 mg/L. This poor water solubility greatly limits the bioavailability of ibuprofen. We aimed to functionalize ibuprofen with xylitol using the reusable immobilized N435 biocatalyst. Instead of a biphasic media, we proposed a monophasic reaction environment. The characterization of the IBU-xylitol ester was performed by 1H, 13C-NMR, DEPT, COSY, HMQC, HMBC, FTIR, and MS spectroscopy. Preliminary in vitro tests showed that this enzymatically synthesized prodrug of ibuprofen reduced the expression of the interleukin 8 genes in human bronchial epithelial cells (IB3-1) from cystic fibrosis (CF) patients.

29 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
RBRiccardo Barbari
Riccardo Barbari
Chiara TupiniChiara Tupini
Chiara Tupini
Elisa DuriniElisa Durini
Elisa Durini
EGEleonora Gallerani
Eleonora Gallerani
FNFrancesco Nicoli
Francesco Nicoli
Stefano ManfrediniStefano Manfredini
Stefano Manfredini
A current trend of research in the health field is toward the discovery of multifunctional compounds, capable of interacting with multiple biological targets, thus simplifying multidrug therapies and improving patient compliance. The aim of this work was to synthesize new multifunctional chemical entities bearing a benzothiazole nucleus, a structure that has attracted increasing interest for the great variety of biological actions that it can perform, and already used as a scaffold in several multifunctional drugs. Compounds are reported, divided into two distinct series, synthetized and tested in vitro for the antioxidant, and include UV-filtering and antitumor activities. DPPH and FRAP tests were chosen to outline an antioxidant activity profile against different radical species. The UV-filtering activity was investigated, pre- and post-irradiation, through evaluation of a O/W sunscreen standard formulation containing 3% of the synthetic compounds. The antitumor activity was investigated both on human melanoma cells (Colo-38) and on immortalized human keratinocytes as a control (HaCat). A good antiproliferative profile in terms of IC50 was chosen as a mandatory condition to further investigate apoptosis induction as a possible cytotoxicity mechanism through the Annexin V test. Compound BZTcin4 was endowed with excellent activity and a selectivity profile towards Colo-38, supported by a good antioxidant capacity and an excellent broad-spectrum photoprotective profile.

24 August 2020 in Oncology Letters
Verified
Journal Article
Open access
PDF file
ILIlaria Lampronti
Ilaria Lampronti
DSDaniele Simoni
Daniele Simoni
RRRiccardo Rondanin
Riccardo Rondanin
RBRiccardo Baruchello
Riccardo Baruchello
CSChiara Scapoli
Chiara Scapoli
Roberto GAMBARIRoberto GAMBARI
Roberto GAMBARI
In order to develop potential anticancer agents stimulating apoptosis, novel 3,4‑isoxazolediamide and 4,5,6,7‑tetrahydro‑isoxazolo‑[4,5‑c]‑pyridine derivatives have been synthetized. The original structures of geldanamycin and radicicol, which are known natural heat shock protein (HSP) inhibitors, were deeply modified because both of them exhibit several drawbacks, such as poor solubility, hepatotoxicity, intrinsic chemical instability or deprivation of the in vivo activity. This novel class of synthetic compounds containing the isoxazole nucleus exhibited potent and selective inhibition of HSP90 in previous studies. Biological assays (focusing on in vitro antiproliferative effects and pro‑apoptotic activity) in human erythroleukemic K562 cells (as a model system referring to tumor cells grown in suspension), glioblastoma U251‑MG and glioblastoma temozolomide (TMZ)‑resistant T98G cell lines (two model systems referring to tumor cells grown attached to the flask), were performed. Almost all isoxazole derivatives demonstrated significant antiproliferative and pro‑apoptotic activities, showing induction of both early and late apoptosis of K562 cells. Different effects were observed on the glioma U251‑MG and T98G cells, depending on the structure of the analogues. Antiproliferative and pro‑apoptotic activities in K562 cells were associated with the activation of the erythroid differentiation program. The present study demonstrated that 3,4‑isoxazolediamide and 4,5,6,7‑tetrahydro‑isoxazolo‑[4,5‑c]‑pyridine derivatives should be considered for in vivo studies focusing on the development of anticancer drugs acting, at least partially, via activation of apoptosis.

24 April 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Chiara TupiniChiara Tupini
Chiara Tupini
MZMatteo Zurlo
Matteo Zurlo
JGJessica Gasparello
Jessica Gasparello
ILIrene Lodi
Irene Lodi
AFAlessia Finotti
Alessia Finotti
Ilaria LamprontiIlaria Lampronti
Ilaria Lampronti
Combined treatments employing lower concentrations of different drugs are used and studied to develop new and more effective anticancer therapeutic approaches. The combination therapy could be of great interest in the controlling of cancer. Regarding this, our research group has recently shown that peptide nucleic acids (PNAs) that target miR-221 are very effective and functional in inducing apoptosis of many tumor cells, including glioblastoma and colon cancer cells. Moreover, in a recent paper, we described a series of new palladium allyl complexes showing a strong antiproliferative activity on different tumor cell lines. The present study was aimed to analyze and validate the biological effects of the most active compounds tested, in combination with antagomiRNA molecules targeting two miRNAs, miR-221-3p and miR-222-3p. The obtained results show that a “combination therapy”, produced by combining the antagomiRNAs targeting miR-221-3p, miR-222-3p and the palladium allyl complex 4d, is very effective in inducing apoptosis, supporting the concept that the combination treatment of cancer cells with antagomiRNAs targeting a specific upregulated oncomiRNAs (in this study miR-221-3p and miR-222-3p) and metal-based compounds represents a promising therapeutic strategy to increase the efficacy of the antitumor protocol, reducing side effects at the same time.